Auszug
Die drei großen Kommunikationssyteme im menschlichen Körper, das Nervensystem, das endokrine System und das Immunsystem, interagieren vielfältig. Bereits in den Schriften der antiken Medizin gibt es humoralpathologische Modellvorstellungen, nach denen die Sekretionen von Körpersäften und das menschliche Verhalten (Temperamente), z. B. schwarze Galle und melancholischer Charakter, einander bedingten. Die klinische (Psycho-) Neuroendokrinologie, die empirisch das Zusammenspiel von Hormonen, Gehirn und Verhalten beim gesunden und kranken Menschen untersucht, ist hingegen ein relativ junges Forschungsfeld. Erst im 20. Jahrhundert wurden die physiologischen Grundlagen etabliert, wie das zentrale Nervensystem (ZNS) durch die Wirkung verschiedenster Neurotransmitter das periphere Endokrinium über die Modulation der Sekretion humoraler hypothalamischer bzw. hypophysärer Botenstoffe steuert.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Literatur
Aemi A, Traber R, Hock C et al (2004) Low-dose cortisol for symptoms of posttraumatic stress disorder. Am J Psychiatry 161: 1488–1490
Ancelin ML, Scali J, Ritchie K (2007) Hormonal therapy and depression: are we overlooking an important therapeutic alternative? J Psychom Res 62: 473–485
Arzt E, Holsboer F (2006) CRF signaling: molecular specificity for drug targeting in the CNS. Trends Pharmacol Sci 27: 531–538
Bauer M, Heinz A, Whybrow PC (2002) Thyroid hormone, serotonin and mood: of synergy and significance in the adult brain. Mol Psychiatry 7: 140–156
Bleuler M (1954) Endokrinologische Psychiatrie. Thieme, Stuttgart
de Kloet ER, Joels M, Holsboer F (2005) Stress and the brain: from adaptation to disease. Nature Rev Neurosci 6: 463–475
DeBattista C, Belanoff J (2006) The us e of mifepristone in the treatment of neuropsychiatric disorders, Trends Endocrinol Metab 17: 117–121
Dunn PJ (1998) Neuroendocrine challenge tests: what can we learn from them? In: Van de, Kar LD (ed) Methods in neuroendocrinology. Springer, Heidelberg, pp 205–233
Fountoulakis KN, Kantartzis S, Siamouli M, Panagiotidis G, Kaprinis S, Lacovides A, Kaprinis G (2006) Peripheral thyroid dysfunction in depression. World J Biol Psychiatry 7: 131–137
Grambsch P, Young EA, Meller WH (2004) Pulsatile luteinzing, hormone disruption in depression. Psychoneuroendocrinology 29: 825–829
Heuser I, Yassouridis A, Holsboer F (1994) The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders. J Psychiatr Res 28: 341–356
Holsboer F (1998) The endocrinology of mental disease. In: Grossman A (ed) Clinical endocrinology. Blackwell Science, Oxford, pp 1096–1113
Holsboer F (1999) The rationale for corticotrophin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety. J Psychiatr Res 33: 181–214
Holsboer F, Gerken A, von Bardeleben U, Grimm W, Stalla GK, Müller OA (1985) Relationship between pituitary responses to human corticotrophin-releasing factor and thyrotropin-releasing hormone in depressives and normal controls. Eur J Pharmacol 110: 153–154
Jahn H, Schick M, Kiefer F, Kellner M, Yassouridis A, Wiedemann K (2004) Metyrapone as additive treatment in major depression: a double-blind and placebo-controlled trial. Arch Gen Psychiatry 61: 1235–1244
Jarrett DB, Kupfer DJ, Miewald JM, Grochocinski VJ, Franz B (1994) Sleep-related growth hormone secretion is persistently suppressed in women with recurrent depression: a preliminary longitudinal analysis. J Psychiatr Res 28: 211–223
Kellner M, Yehuda R (1999) Do panic disorder and posttraumatic stress disorder share a common psychoneuroendocrinology? Psychoneuroendocrinology 24: 485–504
Kellner M, Jahn H, Wiedemann K (2003) Natriuretic peptides and panic disorders: therapeutic prospects. Expert Rev Neurotherapeutics 3: 89–94
Kluge M, Schussler P, Weikel J et al (2006) Altered nocturnal growth hormone (GH) secretion in obsessive compulsive disorder. Psychoneuroendocrinology 31: 1098–1104
Landgraf R (2006) The involvement of the vasopressin system in stress-related disorders. CNS Neurol Disord Drug Targets 5: 167–179
Loosen PT, Prange AJ Jr (1982) Serum thyrotropin response to thyrotropin-releasing hormone in psychiatric patients: a review. Am J Psychiatry 139 405–416
Malison RT, Anand A, Pelton GH et al (1999) Limited efficacy of ketoconazole in treatment-refractory major depression. J Clin Psychopharmacol 19: 466–470
Malven PV (2000) Neurotransmitters as regulators of hypothalamic function. In: Conn PM, Freeman ME (eds) Neuroendocrinology in physiology and medicine. Humana Press, Totowa, NJ, pp 59–73
Peeters BW, Tonnaer JA, Groen MB et al (2004) Glucocorticoid receptor antagonists: a new tool to investigate disorders characterized by cortisol hypersecretion. Stress 7: 233–241
Schatzberg AF (2003) New approaches to managing psychotic depression. J Clin Psychiatry 64(Suppl 1): 19–23
Steiger A (2007) Neurochemical regulation of sleep. J Psychiatr Res 41: 537–352
Wiedemann K, Kellner M (1994) Endocrine characterization of the new dopamine autoreceptor agonist roxindole. Exp Clin Endocrinol 102: 284–288
Wiedemann K, von Bardeleben U, Holsboer F (1991) Influence of h-CRH and ACTH (1–14) upon spontaneous growth hormone secretion. Neuroendocrinology 54: 62–68
Wiedemann K, Jahn H, Yassouridis A, Kellner M (2001) Anxiolytic-like effects of atrial natriuretic peptide upon cholecystokinin-tetrapeptide-induced panic attacks. Arch Gen Psychiatry 58: 371–377
Wolkowitz OM, Reus VI (2003) Neurotransmitters, neurosteroids and neurotrophins: new models of the pathophysiology of depression. World J Biol Psychiatry 4: 98–102
Wolkowitz OM, Reus VI, Chan T, Manfredl F, Raum W, Johnson R, Canick J (1999) Antiglucocorticoid treatment of depression; double-blind ketoconazole. Biol Psychiatry 45: 1070–1074
Yehuda R (2002) Current status of cortisol findings in post-traumatic stress disorder. Psychiatr Clin N Am 25: 341–368
Young EA, Korszun A (2002) The hypothalamic-pituitary-gonadal axis in mood disorders. Endocrinol Metab Clin N Am 31: 63–78
Zobel AW, Nickel T, Kuenzel HE, Ackl N, Sonntag A, Ising M, Holsboer F (2000) Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated. J Psychiatry Res 34: 171–181
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer Medizin Verlag Heidelberg
About this chapter
Cite this chapter
Kellner, M. (2008). Neuroendokrinologie. In: Holsboer, F., Gründer, G., Benkert, O. (eds) Handbuch der Psychopharmakotherapie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-68748-1_15
Download citation
DOI: https://doi.org/10.1007/978-3-540-68748-1_15
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-20475-6
Online ISBN: 978-3-540-68748-1
eBook Packages: Medicine (German Language)